F. Ricciardolo (Orbassano (TO), Italy), R. Louis (Liège, Belgium)
Characterizing healthcare resource use among adults with COPD by presence of comorbidities
M. Barrett (San Diego, United States), V. Vuong (San Diego, United States), E. Boers (Halifax, Canada), A. Cameron (San Diego, United States), L. Kaye (San Diego, United States), C. Woodford (Halifax, Canada), C. Nunez (San Diego, United States), K. Sterling (San Diego, United States)
|   |
Healthcare resource utilization among adults with asthma by disease severity and presence of comorbidities
M. Barrett (San Diego, United States), V. Vuong (San Diego, United States), E. Boers (Halifax, Canada), A. Cameron (San Diego, United States), L. Kaye (San Diego, United States), C. Woodford (Halifax, Canada), C. Nunez (San Diego, United States), K. Sterling (San Diego, United States)
| |
Airflow obstruction as a marker of prognosis in rheumatoid arthritis
A. Denis (4000 Liège, Belgium), C. Regnier (4000 Liège, Belgium), M. Henket (4000 Liège, Belgium), N. Maes (4000 Liège, Belgium), M. Thys (4000 Liège, Belgium), R. Louis (4000 Liège, Belgium), M. Malaise (4000 Liège, Belgium), J. Guiot (4000 Liège, Belgium)
| |
Are obesity and visceral adipose tissue a trait of asthma?
C. Schiffers (Vienna, Austria), A. Ofenheimer (Vienna, Austria), E. Wouters (Vienna, Austria), P. Puchhammer (Vienna, Austria), R. Breyer-Kohansal (Vienna, Austria), M. Breyer (Vienna, Austria), O. Burghuber (Vienna, Austria), R. Louis (Liege, Belgium), S. Hartl (Vienna, Austria)
| |
Early alterations in lung function in a cohort of patients with non-affective psychotic disorder and a control group.
C. Amado Diago (Santander (Cantabria), Spain), A. Viejo Casas (Santander (Cantabria), Spain), J. Vazquez Bourgon (Santander (Cantabria), Spain), J. Agüero Calvo (Santander (Cantabria), Spain), B. Crespo Facorro (Santander (Cantabria), Spain), M. Ruiz Nuñez (Santander (Cantabria), Spain), R. Garastazu (Santander (Cantabria), Spain)
| |
RISK OF IN-HOSPITAL MORTALITY DUE TO COVID-19 IN PATIENTS WITH BRONCHIAL ASTHMA: APPLICATION OF 4C MORTALITY SCALE.
I. DOMINGUEZ ZABALETA (Madrid, Spain), G. Manzanares Cavi (Madrid, Spain), W. Giron Matute (Madrid, Spain), Z. Ji (Madrid, Spain), B. Recio Moreno (Valladolid, Spain), P. Benedetti (Madrid, Spain), A. Oliva Ramos (Madrid, Spain), L. Puente Maestu (Madrid, Spain), J. De Miguel Diez (Madrid, Spain)
| |
Small airway dysfunction detected by oscillometry in asthma, COPD, and asthma-COPD overlap
T. Shirai (Shizuoka, Japan), K. Hirai (Shizuoka, Japan), Y. Gon (Tokyo, Japan)
| |
The association between transfer coefficient of the lung and the risk of exacerbation in asthma-COPD overlap
H. Ogata (Fukuoka, Japan), K. Katahira (Fukuoka, Japan), A. Enokizu-Ogawa (Fukuoka, Japan), Y. Jingushi (Fukuoka, Japan), A. Ishimatsu (Fukuoka, Japan), K. Taguchi (Fukuoka, Japan), A. Moriwaki (Fukuoka, Japan), M. Yoshida (Fukuoka, Japan)
| |
Integrating Care: screening for anxiety and depression in COPD
T. Mason (London, United Kingdom), A. Dewar (London, United Kingdom), J. Hall (London, United Kingdom)
| |
Bronchiectasis on chronic obstructive pulmonary disease patients: what special features?
C. Habouria (Tunis, Tunisia), I. Bachouch (Tunis, Tunisia), N. Balloumi (Tunis, Tunisia), K. Bouguerra (Tunis, Tunisia), N. Khezemi (Tunis, Tunisia), A. Zargouni (Tunis, Tunisia), F. Chermiti (Tunis, Tunisia), S. Fennich (Tunis, Tunisia), I. Bachouch (Ariana, Tunisia)
| |
Impact of COVID-19 on hospital admissions, health status and behavioral changes of patients with severe COPD
E. Pappe (Berlin, Germany), R. Hammerich (Berlin, Germany), J. Saccomanno (Berlin, Germany), L. Erdmann (Berlin, Germany), T. Sgarbossa (Berlin, Germany), M. Witzenrath (Berlin, Germany), N. Suttorp (Berlin, Germany), R. Hübner (Berlin, Germany)
| |
Factors underlying the increasing prevalence of comorbidities over time and their mutual relationship in COPD: Results from COSYCONET
P. Alter (Marburg, Germany), K. Kahnert (Munich, Germany), F. Trudzinski (Heidelberg, Germany), R. Bals (Homburg, Germany), H. Watz (Grosshansdorf, Germany), T. Speicher (Marburg, Germany), S. Söhler (Marburg, Germany), S. Andreas (Immenhausen, Germany), T. Welte (Hannover, Germany), K. Rabe (Grosshansdorf, Germany), E. Wouters (Maastricht, Germany), C. Lange (Borstel, Germany), H. Wirtz (Leipzig, Germany), J. Ficker (Nuremberg, Germany), C. Vogelmeier (Marburg, Germany), R. Jörres (Munich, Germany)
| |
Right heart changes depending on the functional status of patients with COPD combined with hypertension
A. Melenevych (Kharkiv, Ukraine)
| |
Detection of progressive airway disease on chest computed tomography in the Ataluren CF cohort using an airway-artery algorithm
Q. Lv (Rotterdam, Netherlands), L. Gallardo Estrella (Nijmegen, Netherlands), E. Andrinopoulou (Rotterdam, Netherlands), P. Ciet (Rotterdam, Netherlands), J. Charbonnier (Nijmegen, Netherlands), M. P.C. Kemner - Van De Corput (Rotterdam, Netherlands), D. Caudri (Rotterdam, Netherlands), M. De Bruijne (Rotterdam, Netherlands), H. A.W.M. Tiddens (Rotterdam, Netherlands)
| |
Longitudinal variation of nasal nitric oxide in patients with Primary Ciliary Dyskinesia and healthy controls.
C. Pioch (Berlin, Germany), N. Ziegahn (Berlin, Germany), M. Mall (Berlin, Germany), J. Röhmel (Berlin, Germany)
| |
Vocal biomarkers in COPD: capturing disease severity using voice
I. Michels (Maastricht, Netherlands), V. Urovi (Maastricht, Netherlands), H. Strik (Nijmegen, Netherlands), H. Van Helvoort (Nijmegen, Netherlands), S. Simons (Maastricht, Netherlands), I. Michels (Maastricht, Netherlands)
| |
Evolution of asthmatic patients at 6 and 12 months after acute COVID-19 recovery
R. Camperos Moreno (Madrid, Spain), P. Freund (Madrid, Spain), J. Pavón Guede (Madrid, Spain), I. Fernández-Concha Llona (Madrid, Spain), I. De Agrela Mendes (Madrid, Spain), K. Pose (Madrid, Spain), D. Laorden Escudero (Madrid, Spain), D. Romero Ribate (Madrid, Spain), C. Carpio Segura (Madrid, Spain), I. Losantos García (Madrid, Spain), P. Marical Aguilar (Madrid, Spain), I. Fernández Navarro (Madrid, Spain), M. Arnalich Montiel (Madrid, Spain), L. Gómez Carrera (Madrid, Spain), C. Alegre Segura (Madrid, Spain), A. Borobia Pérez (Madrid, Spain), C. Prados Sánchez (Madrid, Spain), S. Quirce (Madrid, Spain), J. Domínguez Ortega (Madrid, Spain), F. Arnalich Fernández (Madrid, Spain), R. Álvarez-Sala Walther (Madrid, Spain)
| |
Vaccination and hospitalization of COVID-19:what difference does it make?
R. Jebali (Tunis, Tunisia), A. Hedhli (Tunis, Tunisia), Y. Ouahchi (Tunis, Tunisia), S. Cheikhrouhou (Tunis, Tunisia), S. Merai (Tunis, Tunisia), S. Toujani (Tunis, Tunisia), M. Mjid (Tunis, Tunisia), B. Dhahri (Tunis, Tunisia), A. Hedhli Ep Cherni (tunis, Tunisia)
| |
Exercise induced laryngeal obstruction in asthma
A. Rogde (Bergen, Norway), S. Lehmann (Bergen, Norway), H. Kvidaland (Bergen, Norway), O. Røksund (Bergen, Norway), H. Clemm (Bergen, Norway), T. Halvorsen (Bergen, Norway), M. Vollsæter (Bergen, Norway), T. Andersen (Bergen, Norway)
| |
Incidental pulmonary emphysema and COPD cases in a national lung cancer screening program feasibility study.
A. Poola (Tartu, Estonia), V. Makke (Tartu, Estonia), M. Frik (Tartu, Estonia), P. Viiklepp (Tartu, Estonia), T. Kiudma (Tartu, Estonia), U. Takker (Tartu, Estonia), A. Rätsep (Tartu, Estonia), K. Laisaar (Tartu, Estonia), T. Laisaar (Tartu, Estonia)
| |